Concordant reductions in total IgE and exhaled nitric oxide during oral steroid withdrawal in severe asthma at high altitude

L. H. Rijssenbeek, K. B. Fieten, A. O. Bron, E. J. Weersink, E. H. Bel (Davos, Switzerland; Amsterdam, Netherlands)

Source: Annual Congress 2009 - Severe asthma and its treatment
Session: Severe asthma and its treatment
Session type: E-Communication Session
Number: 1864
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. H. Rijssenbeek, K. B. Fieten, A. O. Bron, E. J. Weersink, E. H. Bel (Davos, Switzerland; Amsterdam, Netherlands). Concordant reductions in total IgE and exhaled nitric oxide during oral steroid withdrawal in severe asthma at high altitude. Eur Respir J 2009; 34: Suppl. 53, 1864

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High levels of fractional exhaled nitric oxide (FeNO) in severe oral steroid-dependent asthma are associated with eosinophilia and atopy
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

Changes of exhaled nitric oxide during steroid treatment of childhood asthma
Source: Eur Respir J 2002; 19: 1015-1019
Year: 2002



High levels of fractional exhaled nitric oxide (FeNO) only reflect the degree of allergen sensitization in mild childhood asthma
Source: Annual Congress 2005 - Monitoring paediatric asthma
Year: 2005


Tapering oral corticosteroids in severe asthma is associated with a decrease in fractional exhaled nitric oxide
Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases
Year: 2011

Bronchodilator response and previous lung function decline in relation with exhaled nitric oxide levels in asthma
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017

Correlation of exhaled nitric oxide with IgE levels and eosinophils in blood in pediatric asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Serum IgE levels closely reflect blood eosinophilia and fractional exhaled nitric oxide levels but not pulmonary functions in children with mild allergic asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 399s
Year: 2003

Effect of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in atopic asthmatic children
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007


Increased serum levels of IL-8 and TNFα in severe asthma compared to mild asthma: relationship with airway calibre and exhaled nitric oxide (FeNO)
Source: Eur Respir J 2004; 24: Suppl. 48, 351s
Year: 2004

Are exhaled nitric oxide and airway hyperresponsiveness good predictive markers of inhaled corticosteroids dose reduction failures in children?
Source: Annual Congress 2003 - Role of exhaled NO in diagnosis and therapy of childhood asthma
Year: 2003


The impact of diurnal variations, atopy, pollen exposure and pharmacotherapy on exhaled nitric oxide levels
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011


The effect of inhaled steroids on exhaled nitric oxide levels in children with idiopathic bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001

The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006


Effect of adding montelukast to budesonide treatment on exhaled nitric oxide in mild to moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 259s
Year: 2004

Exhaled nitric oxide and carbon monoxide are not markers of disease activity in asthma patients on reducing doses of inhaled steroids: a longitudinal study
Source: Eur Respir J 2001; 18: Suppl. 33, 337s
Year: 2001

The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012

The impact of atopy, pollen exposure and pharmacotherapy on nasal nitric oxide levels
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010


In current smokers fraction of exhaled nitric oxide is not associated with asthma symptoms
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010

Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study
Source: Eur Respir J 2014; 44: 1705-1707
Year: 2014


Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002